BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36331678)

  • 1. Childhood lymphoma treatment impacts educational outcomes: a registry study from Sweden.
    Lönnerblad M; Suominen R; Harila-Saari A
    J Cancer Surviv; 2023 Aug; 17(4):1072-1081. PubMed ID: 36331678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scholastic achievement of children with lymphoma or Wilms tumor at the end of comprehensive education--a nationwide, register-based study.
    Lähteenmäki PM; Sankila R; Pukkala E; Kyyrönen P; Harila-Saari A
    Int J Cancer; 2008 Nov; 123(10):2401-5. PubMed ID: 18651572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
    Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
    J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Season of birth and risk of Hodgkin and non-Hodgkin lymphoma.
    Crump C; Sundquist J; Sieh W; Winkleby MA; Sundquist K
    Int J Cancer; 2014 Dec; 135(11):2735-9. PubMed ID: 24752499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study.
    Busson R; van der Kaaij M; Mounier N; Aleman BMP; Thiéblemont C; Stamatoullas A; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Kluin-Nelemans HC; Henry-Amar M
    Health Qual Life Outcomes; 2019 Jul; 17(1):115. PubMed ID: 31266501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany.
    Gebauer J; Fick EM; Waldmann A; Langer T; Kreitschmann-Andermahr I; Lehnert H; Katalinic A; Brabant G
    Eur J Endocrinol; 2015 Aug; 173(2):139-48. PubMed ID: 25947143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide, population-based study of school grades, delayed graduation, and qualification for school years 10-12, in children with brain tumors in Sweden.
    Lönnerblad M; Van't Hooft I; Blomgren K; Berglund E
    Pediatr Blood Cancer; 2020 Feb; 67(2):e28014. PubMed ID: 31595683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Level of education and the risk of lymphoma in the European prospective investigation into cancer and nutrition.
    Hermann S; Rohrmann S; Linseisen J; Nieters A; Khan A; Gallo V; Overvad K; Tjønneland A; Raaschou-Nielsen O; Bergmann MM; Boeing H; Becker N; Kaaks R; Bueno-de-Mesquita HB; May AM; Vermeulen RC; Bingham S; Khaw KT; Key TJ; Travis RC; Trichopoulou A; Georgila C; Triantafylou D; Celentano E; Krogh V; Masala G; Tumino R; Agudo A; Altzibar JM; Ardanaz E; Martínez-García C; Suárez MV; Tormo MJ; Braaten T; Lund E; Manjer J; Zackrisson S; Hallmans G; Malmer B; Boffetta P; Brennan P; Slimani N; Vineis P; Riboli E
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):71-7. PubMed ID: 19582474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density in pediatric survivors of Hodgkin and non-Hodgkin lymphomas.
    Muszynska-Roslan K; Latoch E; Konstantynowicz J; Panasiuk A; Stewart A; Krawczuk-Rybak M
    Adv Med Sci; 2014 Sep; 59(2):200-5. PubMed ID: 25323758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.
    Youlden DR; Gupta S; Frazier AL; Moore AS; Baade PD; Valery PC; Green AC; Aitken JF
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27683. PubMed ID: 30803139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and birth anthropometric characteristics in relation to the risk of childhood lymphomas: a Swedish nationwide cohort study.
    Petridou ET; Sergentanis TN; Skalkidou A; Antonopoulos CN; Dessypris N; Svensson T; Stephansson O; Kieler H; Smedby KE
    Eur J Cancer Prev; 2015 Nov; 24(6):535-41. PubMed ID: 25569452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia and lymphoma incidence in children in Alberta, Canada: a population-based 22-year retrospective study.
    Kulkarni K; Stobart K; Witol A; Rosychuk RJ
    Pediatr Hematol Oncol; 2011 Nov; 28(8):649-60. PubMed ID: 21981741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased healthcare use up to 10 years among relapse-free Hodgkin lymphoma survivors in the era of intensified chemotherapy and limited radiotherapy.
    Glimelius I; Eloranta S; Ekberg S; Chang ET; Neovius M; Smedby KE
    Am J Hematol; 2017 Mar; 92(3):251-258. PubMed ID: 28006849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.
    Glimelius I; Ekberg S; Linderoth J; Jerkeman M; Chang ET; Neovius M; Smedby KE
    J Cancer Surviv; 2015 Dec; 9(4):599-609. PubMed ID: 25689964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of treatment, socio-demographic and clinical characteristics on health-related quality of life among Hodgkin's and non-Hodgkin's lymphoma survivors: a systematic review.
    Oerlemans S; Mols F; Nijziel MR; Lybeert M; van de Poll-Franse LV
    Ann Hematol; 2011 Sep; 90(9):993-1004. PubMed ID: 21670973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.